Alzheimer's

News

Hope for Alzheimer’s treatment after promising study results

Biogen and Eisai said their latest clinical study confirmed the amyloid hypothesis and might lead to the first drug successfully treating Alzheimer’s disease, instantly bumping their share

News

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

The battle to develop a drug to treat Alzheimer’s disease has been dealt a blow following disappointing phase 3 trial results.

News

Biogen’s Alzheimer’s drug, elenbecestat, shows early promise

A trial of Biogen’s Alzheimer’s disease drug elenbecestat has had promising results in mild to moderate forms of the disease.

News

Closeup of X-ray photography of human brain

vTv's azeliragon is latest Alzheimer's drug failure

vTv to stop all studies after STEADFAST trial failure

News

Celgene pursues neuro breakthrough with $150m Prosena deal

Celgene is pushing further into the field of neuroscience and dementia research with an alliance with Dublin-based biotech Prosena.

Views & Analysis

Digital in action against Alzheimer’s disease

Digital technologies are both helping to transform the public’s perception of dementia, and enabling everyone to help scientific research into the disease by playing a smartphone game that tests navigation skills.

Hope for Alzheimer’s treatment after promising study results

AstraZeneca and Lilly’s Alzheimer’s drug fails trial

Biogen’s Alzheimer’s drug, elenbecestat, shows early promise

vTv's azeliragon is latest Alzheimer's drug failure

Celgene pursues neuro breakthrough with $150m Prosena deal

Digital in action against Alzheimer’s disease

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's

Editor's Picks